Meet with us at booth #25.
As a Gold Sponsor for the third annual Spatial Biology East Coast Congress in Boston, we hope you’ll join our experts and over 350 other industry leaders to discuss the transforming field of spatial biology. Examine how spatial biology can facilitate biomarker discovery, applications for the acceleration of drug development, integration of spatial transcriptomics with multiplex imaging, and more.
Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance your precision medicine strategy. Spatially visualizing drug activity with unparalleled precision, we support discovery and target engagement decisions that transcend conventional approaches. With seventeen US patents backing our proprietary image analysis technology, Flagship partners with you to deliver customized data to meet your needs, including:
- AI-powered digital pathology solutions
- Biomarker development and validation
- Spatial biology and molecular diagnostics analysis
- Clinical trial support
- CDx development
- Regulatory guidance
Interested in partnering with us? Meet with us to discuss how our spatial biology solutions can accelerate your research or drug development program.
Tom Turi, Ph.D.
Chief Scientific Officer at Flagship Biosciences
Monday, June 10, 2024
10:40 AM ET
Enhancing Targeted Therapeutics with Spatial Biology
Since 2009, Flagship Biosciences has led the way in spatial biology, being among the first to utilize machine learning and AI for spatial analysis. In this session, Dr. Turi will discuss how Flagship’s SPATIALPlex Solutions™ are revolutionizing precision medicine and enabling clients to visualize molecular interactions in tissues, enhance patient diagnostics, improve treatment options, and further drug development programs.
11:55 AM ET
Intersection of Digital Pathology & Spatial Biology
Dr. Turi will join a panel of other industry experts to discuss the incorporation of spatial omics into digital pathology, challenges associated with selecting anatomically matched cases and controls, and applications in digital pathology.
Gene Expression Analysis Within Spatial Context
- Ability to rapidly translate your basic science discoveries into actionable clinical insights using state-of-the-art sequencing platforms from NanoString
- Combination of standard immunofluorescence techniques with digital optical barcoding technology to perform spatial, highly multiplexed, tissue profiling
- Wide range of standard and customizable gene expression panels
The Digital Pathology Advantage
- Improve ROI, accelerate trials, and minimize budget impacts
- Minimize recruitment costs and other clinical trial expenses
- Pathologist-directed image analysis using industry-standard scanning technology, including Akoya PhenoImager™ HT for multiplex fluorescent scanning.
Validated Assays for Clinical Research & Drug Development
- Customizable options optimized to your needs and validation requirements
- Ability to create multiplex assays to characterize complex cellular interactions
Driving Your Biomarker Strategy: Facts by numbers
- View our resume and history to learn why Flagship is the premier partner for your study
- See the full list of spatial biology services that empower confident clinical decision making
- See the benefits with a fully integrated team of scientists and pathologists